Our goal is to assist psychiatrist and mental health clinician to provide a patient centric approach whilst improving efficacy and reducing side effects of treatment.
Our products range from personalised plans for treatment resistant depression to monitoring tools that ease with record keeping. These solutions are validated by clinicians and mental health professionals. Meeting the current needs in patient care.
Led by practicing clinicians, the solutions we provide are tailored to the current limitations that doctor and patients face, in the already strained mental health care system. Our tools are not just an algorithm, but a personalized approach for each individual need.
Mano AI is an advanced artificial intelligence platform designed to help individuals and businesses work smarter and more efficiently by providing intelligent assistance for content creation, problem-solving, research, and everyday productivity tasks. It understands natural language and delivers fast, accurate, and useful responses, making it easy for users to generate ideas, write content, get clear explanations, and receive step-by-step guidance across a wide range of topics. Built with simplicity, speed, and user experience in mind, Mano AI adapts to different needs and serves as a reliable digital companion for students, creators, professionals, and businesses looking to save time, boost creativity, and achieve more.
Erandi is a final year PhD candidate at the University of Technology. She has a passion for translating medical research into meaningful products that address real world challenges. For more than 10 years, she has contributed to research in neuroscience, with publications in high impact journals. This has provided valuable background into conducting evidence-based research, with thorough testing and validation.
Her doctoral research focuses on developing innovative solutions for patients undergoing antipsychotic treatment. Recognizing the need for a more personalized approach and the limitations of current psychiatric methods, she was motivated to develop a solution using novel artificial intelligence models.
Beyond her academic contributions, Erandi is driven by the broader impact of her work improving patient care, shaping the future of clinical technologies, and advancing the role of artificial intelligence in healthcare. She firmly believes that artificial intelligence has the capacity to meet the ever-increasing demands of psychiatric care, making patient care more affordable and accessible.
Dr Alistair Carroll is an advanced trainee in forensic psychiatry and researcher. He has an interest in work that bridges cutting edge artificial intelligence with the complexities of human mental health. He has clinical expertise in interventional psychiatric treatments such as ECT, TMS, tDCS and ketamine and is committed to advancing ethical, evidence-based innovation in psychiatry.
Currently completing a PhD at the University of New South Wales under the supervision of Professor Colleen Loo, Alistair’s research explores how computational modelling and neuroimaging can refine brain stimulation therapies. His recent publications in the Journal of ECT demonstrate how cranial sutures alter computational models of transcranial electrical stimulation work that is reshaping how clinicians and engineers approach next-generation neuromodulation tools.
He has presented his research at national and international conferences, including the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Congress, and was awarded the HETI Psychiatry Special Training Award for establishing a new neurostimulation service at The Forensic Hospital.
Alistair is equally passionate about the responsible integration of AI into psychiatry. His focus is on harnessing technology to improve patient care while safeguarding ethical standards and equity. At the heart of his work is a vision: to pioneer AI enabled, personalized mental health interventions that are clinically rigorous, ethically grounded, and accessible to those who need them most.